Johns Hopkins ABX Guide
Loracarbef
INDICATIONS
FDA
FDA
- No longer available in the U.S.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Acute otitis media
- Acute exacerbations of chronic bronchitis secondary bacterial infection of acute bronchitis
- Acute maxillary sinusitis
- Uncomplicated and complicated UTI.
- Pharyngitis/tonsillitis
- Community-acquired (CAP) caused by S. pneumoniae or H. influenzae (non-β-lactamase-producing strains only)
- Skin and skin-structure infections (impetigo)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 7, 2019
Citation
Avdic, Edina, and Paul A Pham. "Loracarbef." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540323/all/Loracarbef.
Avdic E, Pham PA. Loracarbef. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540323/all/Loracarbef. Accessed November 3, 2025.
Avdic, E., & Pham, P. A. (2019). Loracarbef. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540323/all/Loracarbef
Avdic E, Pham PA. Loracarbef [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2025 November 03]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540323/all/Loracarbef.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Loracarbef
ID - 540323
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2019/03/07/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540323/all/Loracarbef
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
